The study: Roberts ET, Schmajuk G, Li J, et al. Latent tuberculosis screening among new users of a biologic or targeted synthetic disease-modifying antirheumatic drug: Gaps in screening overall and among Janus kinase inhibitors. Arthritis Care Res (Hoboken). 2024 Jul;76(7): 1037–1044.
Related Articles
Capillaroscopy a Safe and Direct Method for SSc Diagnosis
Seeing vessels clearly can help with discovery and timely treatment
Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease
No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.
Progress Continues in Systemic Sclerosis
Advances in genetics and potential therapies shed new light on the disease
The Heart-SCC Puzzle
Identifying and treating cardiac involvement in systemic sclerosis can be a challenge